JP2007531739A5 - - Google Patents

Download PDF

Info

Publication number
JP2007531739A5
JP2007531739A5 JP2007506356A JP2007506356A JP2007531739A5 JP 2007531739 A5 JP2007531739 A5 JP 2007531739A5 JP 2007506356 A JP2007506356 A JP 2007506356A JP 2007506356 A JP2007506356 A JP 2007506356A JP 2007531739 A5 JP2007531739 A5 JP 2007531739A5
Authority
JP
Japan
Prior art keywords
formula
alkyl
compound
aryl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007506356A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007531739A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/011357 external-priority patent/WO2005097788A2/en
Publication of JP2007531739A publication Critical patent/JP2007531739A/ja
Publication of JP2007531739A5 publication Critical patent/JP2007531739A5/ja
Withdrawn legal-status Critical Current

Links

JP2007506356A 2004-04-02 2005-04-04 スルホンアミドおよびそれらの使用 Withdrawn JP2007531739A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55916604P 2004-04-02 2004-04-02
PCT/US2005/011357 WO2005097788A2 (en) 2004-04-02 2005-04-04 Sulfonamides and uses thereof

Publications (2)

Publication Number Publication Date
JP2007531739A JP2007531739A (ja) 2007-11-08
JP2007531739A5 true JP2007531739A5 (enExample) 2008-05-15

Family

ID=35125664

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007506356A Withdrawn JP2007531739A (ja) 2004-04-02 2005-04-04 スルホンアミドおよびそれらの使用

Country Status (5)

Country Link
US (1) US20050261332A1 (enExample)
EP (1) EP1789409A4 (enExample)
JP (1) JP2007531739A (enExample)
CA (1) CA2561801A1 (enExample)
WO (1) WO2005097788A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6374762B1 (en) * 1997-10-27 2002-04-23 Correct Craft, Inc. Water sport towing apparatus
EP1483283A4 (en) 2002-03-13 2007-04-11 Signum Biosciences Inc MODULATION OF PROTEIN METHYLATION AND PHOSPHOPROTEIN PHOSPHATE
EP1682136A4 (en) * 2003-11-04 2009-06-03 Elixir Pharmaceuticals Inc THERAPEUTIC COMPOUNDS AND CORRESPONDING USES THEREOF
RU2007109794A (ru) 2004-08-19 2008-09-27 Вертекс Фармасьютикалз, Инкорпорейтед (Us) Модуляторы мускариновых рецепторов
US7786141B2 (en) * 2004-08-19 2010-08-31 Vertex Pharmaceuticals Incorporated Dihydrospiroindene modulators of muscarinic receptors
WO2006036932A2 (en) * 2004-09-27 2006-04-06 Elixir Pharmaceuticals, Inc. Sulfonamides and uses thereof
WO2006058303A2 (en) * 2004-11-29 2006-06-01 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
WO2006084033A1 (en) 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US7829589B2 (en) * 2005-06-10 2010-11-09 Elixir Pharmaceuticals, Inc. Sulfonamide compounds and uses thereof
EA200800013A1 (ru) * 2005-06-10 2008-06-30 Эликсир Фармасьютикалз, Инк. Сульфонамидные соединения и их применение
AU2006330866A1 (en) * 2005-12-22 2007-07-05 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
RU2008137583A (ru) * 2006-02-22 2010-03-27 Вертекс Фармасьютикалз Инкорпорейшн (Us) Спиропиперидины в качестве модуляторов мускариновых рецепторов
RU2008137593A (ru) * 2006-02-22 2010-03-27 Вертекс Фармасьютикалз Инкорпорейтед (Us) Модуляторы мускариновых рецепторов
US7858790B2 (en) * 2006-06-29 2010-12-28 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP2051712A2 (en) * 2006-08-15 2009-04-29 Vertex Pharmceuticals Incorporated Modulators of muscarinic receptors
AU2007284350A1 (en) 2006-08-18 2008-02-21 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
WO2008024497A2 (en) * 2006-08-25 2008-02-28 Vitae Pharmaceuticals, Inc. INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1
EP2207549A1 (en) * 2007-10-03 2010-07-21 Vertex Pharmceuticals Incorporated Modulators of muscarinic receptors
AU2009239430B2 (en) 2008-04-21 2015-01-22 Signum Biosciences, Inc. Compounds, compositions and methods for making the same
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AU2010313282A1 (en) 2009-10-30 2012-05-24 Ocera Therapeutics, Inc. Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
CN102762572A (zh) 2010-02-01 2012-10-31 诺瓦提斯公司 作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
JP5748777B2 (ja) 2010-02-02 2015-07-15 ノバルティス アーゲー Crf受容体アンタゴニストとしてのシクロヘキシルアミド誘導体

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726319A (en) * 1992-11-06 1998-03-10 Merck & Co., Inc. Biphenyl substituted dipeptide analogs promote release of growth hormone
NZ258412A (en) * 1992-12-11 1997-01-29 Merck & Co Inc Spiro-fused piperidine derivatives and pharmaceutical compositions
US5536716A (en) * 1992-12-11 1996-07-16 Merck & Co., Inc. Spiro piperidines and homologs which promote release of growth hormone
US5494919A (en) * 1993-11-09 1996-02-27 Merck & Co., Inc. 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
US5492920A (en) * 1993-12-10 1996-02-20 Merck & Co., Inc. Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
US5492916A (en) * 1993-12-23 1996-02-20 Merck & Co., Inc. Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
US5721251A (en) * 1993-12-10 1998-02-24 Merck & Co., Inc. Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
US5721250A (en) * 1993-12-23 1998-02-24 Merck & Co. Inc. Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
US5783582A (en) * 1994-07-20 1998-07-21 Merck & Co., Inc. Piperidines and hexahydro-1H-azepines spiro substituted at the 4-position promote release of growth hormone
US5559128A (en) * 1995-04-18 1996-09-24 Merck & Co., Inc. 3-substituted piperidines promote release of growth hormone
US5767124A (en) * 1995-10-27 1998-06-16 Merck & Co., Inc. Polymorphic forms of a growth hormone secretagogue
WO1997022367A1 (en) * 1995-12-20 1997-06-26 Merck & Co., Inc. Radiolabeled growth hormone secretagogue
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
GB9612276D0 (en) * 1996-06-12 1996-08-14 Merck & Co Inc 4-Spiroindoline piperidines promote release of growth hormone
US5877182A (en) * 1996-09-13 1999-03-02 Merck & Co., Inc. Piperidines promote release of growth hormone
DE69837264T2 (de) * 1997-06-25 2008-01-31 Pfizer Inc. Dipeptidverbindungen, die Wachstumshormon-Sekretagoga sind
UA53716C2 (uk) * 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
US6358951B1 (en) * 1998-08-21 2002-03-19 Pfizer Inc. Growth hormone secretagogues
US6194578B1 (en) * 1998-11-20 2001-02-27 Pfizer Inc. Dipeptide derivatives
ES2219368T3 (es) * 1999-07-13 2004-12-01 MERCK & CO., INC. Amidoespiropiperidinas que promueven la liberacion de la hormona de crecimiento.
EP1682136A4 (en) * 2003-11-04 2009-06-03 Elixir Pharmaceuticals Inc THERAPEUTIC COMPOUNDS AND CORRESPONDING USES THEREOF

Similar Documents

Publication Publication Date Title
JP2007531739A5 (enExample)
JP2009535356A5 (enExample)
JP2012522056A5 (enExample)
JP2007510662A5 (enExample)
JP2007514646A5 (enExample)
JP2005112864A5 (enExample)
JP2005507872A5 (enExample)
JP2009533410A5 (enExample)
JP2009534398A5 (enExample)
JP2013533317A5 (enExample)
JP2013528602A5 (enExample)
JP2008525416A5 (enExample)
EP2457918A3 (en) Crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl) methyl) phenyl)-d-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes
RU2436785C2 (ru) Гетеробициклические карбоксамиды в качестве ингибиторов киназ
EP1325921A3 (en) Oxo or oxy-pyridine compounds as 5-HT4 receptor modulators
JP2005523310A5 (enExample)
JP2011522789A5 (enExample)
JP2011512412A5 (enExample)
JP2010523570A5 (enExample)
JP2005534627A5 (enExample)
JP2009516697A5 (enExample)
CA2536870A1 (en) Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
JP2009534468A5 (enExample)
JP2008526724A5 (enExample)
NO20072632L (no) Oksadiazolderivater som DGAT-inhibitorer